Trials / Unknown
UnknownNCT01340339
Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants
Efficacy of Reverse Phototherapy With Super Light-emitting Diode(Super-led) in Term and Late Preterm Infants:Randomized and Controlled Clinical Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Professor Fernando Figueira Integral Medicine Institute · Academic / Other
- Sex
- All
- Age
- 35 Weeks – 41 Weeks
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare the efficacy of super-LED reverse phototherapy with the fluorescent reverse phototherapy in term and late preterm newborns.
Detailed description
This is a randomized controlled clinical trial with hospitalized infants in the Professor Fernando Figueira Medicine Institute(IMIP), who require phototherapy as an indication of the medical team. Following the sample calculation, 144 patients will be randomized according to gestational age (350/7-376/7 or 380/7-416/7 weeks) to receive super-LED reverse phototherapy or fluorescent reverse phototherapy with spectral irradiance of 8-12 microwatts/cm2/nm.The bilirubin will be determined by micromethod with bilirubinometer, after blood collection in heparinized capillary until bilirubin reaches level that indicates suspension of therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Phototherapy | Fluorescent reverse phototherapy (7 white lights 5cm below the base of acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy |
| DEVICE | Phototherapy | super LED reverse phototherapy (17 bulbs arranged in 42 x 31 cm in blue base acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-10-01
- Completion
- 2012-01-01
- First posted
- 2011-04-22
- Last updated
- 2011-04-22
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01340339. Inclusion in this directory is not an endorsement.